<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pharmaceutical Product Guide &#187; Duramed</title>
	<atom:link href="http://www.pharmaceuticalproductguide.com/blog/tag/duramed/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.pharmaceuticalproductguide.com/blog</link>
	<description>A comprehensive guide to pharmaceutical products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 09:15:33 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>FDA approves Duramed&#8217;s LoSEASONIQUE(R) oral contraceptive</title>
		<link>http://www.pharmaceuticalproductguide.com/blog/2008/10/29/fda-approves-durameds-loseasoniquer-oral-contraceptive/</link>
		<comments>http://www.pharmaceuticalproductguide.com/blog/2008/10/29/fda-approves-durameds-loseasoniquer-oral-contraceptive/#comments</comments>
		<pubDate>Wed, 29 Oct 2008 06:43:40 +0000</pubDate>
		<dc:creator>Kimberly O'Brien</dc:creator>
				<category><![CDATA[FDA Approval]]></category>
		<category><![CDATA[Oral Contraceptives]]></category>
		<category><![CDATA[Barr Pharmaceuticals]]></category>
		<category><![CDATA[Duramed]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[LoSEASONIQUE(R)]]></category>
		<category><![CDATA[oral contraceptive]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalproductguide.com/blog/2008/10/29/fda-approves-durameds-loseasoniquer-oral-contraceptive/</guid>
		<description><![CDATA[The U.S. Food and Drug Administration has approved Duramed Pharmaceuticals’ LoSEASONIQUE(R) extended-cycle oral contraceptive. The product is the first lower-dose, extended-cycle oral contraceptive approved for the prevention of pregnancy. The LoSEASONIQUE(R) regimen requires women to take combination tablets for 84 consecutive days, followed by 0.01 mg ethinyl estradiol tablets for a week. The treatment reduces [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.pharmaceuticalproductguide.com/blog/wp-content/uploads/2008/10/barr.png" align="left" height="109" hspace="5" vspace="5" width="200" />The U.S. Food and Drug Administration has approved Duramed Pharmaceuticals’ LoSEASONIQUE(R) extended-cycle oral contraceptive. The product is the first lower-dose, extended-cycle oral contraceptive approved for the prevention of pregnancy. The LoSEASONIQUE(R) regimen requires women to take combination tablets for 84 consecutive days, followed by 0.01 mg ethinyl estradiol tablets for a week. The treatment reduces the periods of withdrawal bleeding to four from 13 per year.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalproductguide.com/blog/2008/10/29/fda-approves-durameds-loseasoniquer-oral-contraceptive/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
